Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program

BACKGROUND: Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometabolic events and outcomes. In clinical trials, participants with T2D randomized to sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown mild to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Katherine M., Li, JingWei, Bhalla, Vivek, Jardine, Meg J., Neal, Bruce, de Zeeuw, Dick, Fulcher, Greg, Perkovic, Vlado, Mahaffey, Kenneth W., Chang, Tara I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279612/
https://www.ncbi.nlm.nih.gov/pubmed/34277971
http://dx.doi.org/10.1002/edm2.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279612/
https://www.ncbi.nlm.nih.gov/pubmed/34277971
http://dx.doi.org/10.1002/edm2.247

Ejemplares similares